Xiaodong Wang
CIK: 0001662982
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BeOne Medicines Ltd.
Discretionary Trading P&L
Holdings
Transaction History (130 total)
- Oct 27, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct1.4K shares at avg. $355.62$512K - Oct 27, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct1.3K shares at avg. $359.72$460K - Oct 27, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct8.1K shares at avg. $363.24$3.0M - Oct 27, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct2.8K shares at avg. $363.95$1.0M - Oct 27, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct2.3K shares at avg. $362.35$845K - Oct 27, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct1.7K shares at avg. $358.75$603K - Oct 27, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct4K shares at avg. $365.43$1.4M - Oct 27, 2026ONC
BeOne Medicines Ltd.
Exercise(M)Direct31K shares at avg. $36.90$1.1M - Oct 27, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct1.2K shares at avg. $357.54$443K - Oct 27, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct320 shares at avg. $360.64$115K - Oct 27, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct880 shares at avg. $355.56$313K - Oct 27, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct6.9K shares at avg. $366.22$2.5M - Oct 13, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct6.6K shares at avg. $352.57$2.3M - Oct 13, 2026ONC
BeOne Medicines Ltd.
Exercise(M)Direct31K shares at avg. $36.90$1.1M - Oct 13, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct5.7K shares at avg. $351.40$2.0M - Oct 13, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct10.4K shares at avg. $350.47$3.6M - Oct 13, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct7.2K shares at avg. $349.56$2.5M - Oct 13, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct1.3K shares at avg. $353.24$445K - Sep 28, 2026ONC
BeOne Medicines Ltd.
Exercise(M)Direct31K shares at avg. $36.90$1.1M - Sep 28, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct160 shares at avg. $356.97$57K - Sep 28, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct738 shares at avg. $367.23$271K - Sep 28, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct2.2K shares at avg. $361.05$809K - Sep 28, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct40 shares at avg. $359.16$14K - Sep 28, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct4.2K shares at avg. $362.17$1.5M - Sep 28, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct3.4K shares at avg. $364.07$1.2M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 27, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 1,440 | $355.62 | $512,087 | Direct |
| Oct 27, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 1,280 | $359.72 | $460,444 | Direct |
| Oct 27, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 8,148 | $363.24 | $2,959,696 | Direct |
| Oct 27, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 2,841 | $363.95 | $1,033,980 | Direct |
| Oct 27, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 2,331 | $362.35 | $844,639 | Direct |
| Oct 27, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 1,681 | $358.75 | $603,052 | Direct |
| Oct 27, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 3,965 | $365.43 | $1,448,927 | Direct |
| Oct 27, 2026 | ONC BeOne Medicines Ltd. | Exercise(M) | 31,028 | $36.90 | $1,144,933 | Direct |
| Oct 27, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 1,239 | $357.54 | $442,990 | Direct |
| Oct 27, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 320 | $360.64 | $115,404 | Direct |
| Oct 27, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 880 | $355.56 | $312,892 | Direct |
| Oct 27, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 6,903 | $366.22 | $2,528,020 | Direct |
| Oct 13, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 6,558 | $352.57 | $2,312,148 | Direct |
| Oct 13, 2026 | ONC BeOne Medicines Ltd. | Exercise(M) | 31,027 | $36.90 | $1,144,896 | Direct |
| Oct 13, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 5,681 | $351.40 | $1,996,280 | Direct |
| Oct 13, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 10,361 | $350.47 | $3,631,262 | Direct |
| Oct 13, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 7,167 | $349.56 | $2,505,306 | Direct |
| Oct 13, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 1,260 | $353.24 | $445,078 | Direct |
| Sep 28, 2026 | ONC BeOne Medicines Ltd. | Exercise(M) | 31,028 | $36.90 | $1,144,933 | Direct |
| Sep 28, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 160 | $356.97 | $57,115 | Direct |
| Sep 28, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 738 | $367.23 | $271,012 | Direct |
| Sep 28, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 2,241 | $361.05 | $809,120 | Direct |
| Sep 28, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 40 | $359.16 | $14,366 | Direct |
| Sep 28, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 4,239 | $362.17 | $1,535,228 | Direct |
| Sep 28, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 3,419 | $364.07 | $1,244,747 | Direct |
1-25 of 130 transactions
About Wang Xiaodong
Wang Xiaodong (SEC CIK 0001662982) files insider reports with the SEC as Director of BeOne Medicines Ltd. (ONC).
Signal8 holds 18 ownership filings by Wang Xiaodong, all Form 4s, filed between Nov 29, 2024 and Oct 29, 2026. Those filings report 130 transactions, from Nov 26, 2024 to Oct 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wang Xiaodong's filings is in BASEL.
Recent filings by Wang Xiaodong
- Oct 27, 2026: Open-market sales of ONC shares (7 lines, Form 4, code S).
- Oct 27, 2026: Option exercise of ONC shares (Form 4, code M).
- Oct 27, 2026: Open-market sales of ONC shares (4 lines, Form 4, code S).
- Oct 13, 2026: Open-market sale of ONC shares (Form 4, code S).
- Oct 13, 2026: Option exercise of ONC shares (Form 4, code M).
Other insiders filing for BeOne Medicines Ltd. (ONC)
- Lee Chan Henry, SVP, General Counsel
- Ball Titus B., Principal Accounting Officer
- Wu Xiaobin, President and COO
- OYLER JOHN, Chief Executive Officer
- Rosenberg Aaron, Chief Financial Officer
- Wang Lai, President, Global Head of R&D